Activation of latent TGF-beta by integrins
Activation of latent TGF-beta by integrins
批准号:
6921339
负责人:
John S Munger
金额:
$42.25万
依托单位国家:
美国
项目类别:
财政年份:
2000
资助国家:
美国
项目状态:
已结题
起止时间:
2000-02-07 至 2008-06-30
中文摘要
描述(由申请人提供):TGFbeta是一种多效性细胞因子,存在3种亚型,参与多种肺部过程和疾病,如发育、肺纤维化、肺结核、哮喘气道重塑和癌症。tgf - β的生物利用度在细胞外空间受到严格调控:tgf - β以潜伏形式分泌,通过接合蛋白(LTBP)的作用隔离在基质结合位点,并且必须在其通过tgf - β受体发出信号之前被激活。TGFbeta潜伏期的发生是与TGFbeta前肽潜伏期相关肽(LAP)结合的结果,激活涉及从LAP释放TGFbeta。
英文摘要
DESCRIPTION (provided by applicant): TGFbeta, which exists in 3 isoforms, is a pleiotropic cytokine involved in a variety of lung processes and diseases, e.g., development, pulmonary fibrosis, tuberculosis, asthmatic airway remodeling and cancer. TGFbeta bioavailability is tightly regulated in the extracellular space: TGFbeta is secreted in a latent form, which is sequestered in matrix binding sites by the action of an adapter protein (LTBP), and must be activated before it can signal via TGFbeta receptors. TGFbeta latency occurs as a result of binding to the TGFbeta propeptide Latency-Associated Peptide (LAP), and activation involves releasing TGFbeta from LAP.
Because all TGFbeta signaling occurs subsequent to TGFbeta activation, the activation mechanisms are critical control points. Mechanisms of TGFbeta activation have been proposed (e.g., thrombospondin-1, proteases and oxidants), but their roles in vivo are unclear. We showed that an epithelium-specific integrin, alphaVbeta6, binds latent TGFbeta1 at an RGD sequence within LAP. Cells expressing alphaVbeta6 activate TGFbeta1, and mice lacking alphaVbeta6 do not develop bleomycin-induced pulmonary fibrosis. We have also shown that alphaVbeta6 can activate TGFbeta3, and that another integrin expressed in lung epithelium (alphaVbeta8) can activate TGFbeta1/3.
The goal of this work is to define the role of integrin-mediated TGFbeta1 activation in vivo. To that end, we have generated knockin mice with a mutation in the TGFbeta1 gene that encodes a nonfunctional integrin-binding site in the LAP propeptide. The phenotype of these mice (designated TGFbeta1-RGE) reproduces the most prominent aspect of the TGFbeta1-/- phenotype: severe, multiorgan inflammation that causes death at 3-4 weeks of age. This important finding suggests the possibility that integrin-mediated TGFbeta1 activation occurs upstream of most TGFbeta1 effects. The specific aims of this work are to (1) characterize the TGFbeta1-RGE mice in comparison to TGFbeta1-/- mice, (2) test the hypothesis that the only TGFbeta1-activating integrins in vivo are alphaVbeta6 and alphaVbeta8, and (3) test the hypothesis that the phenotype of certain integrin KO mice (alphaV-/- and (beta8-/-) is due to combined lack of TGFbeta1 and TGFbeta3 activation. These studies will further delineate the role of RGD-binding integrins in TGFbeta biology and provide a basis for important studies of their role in lung pathology.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Hedgehog signaling in lung growth and injury
-
批准号:8764614
-
项目类别:
-
资助金额:$10.59万
-
财政年份:2013
-
负责人:John S Munger
-
依托单位:
Hedgehog signaling in lung growth and injury
-
批准号:8106249
-
项目类别:
-
资助金额:$21.13万
-
财政年份:2010
-
负责人:John S Munger
-
依托单位:
Hedgehog signaling in lung growth and injury
-
批准号:7978070
-
项目类别:
-
资助金额:$25.35万
-
财政年份:2010
-
负责人:John S Munger
-
依托单位:
avb6-mediated TGFb activation in radiation lung fibrosis
-
批准号:7116402
-
项目类别:
-
资助金额:$41.26万
-
财政年份:2004
-
负责人:John S Munger
-
依托单位:
avb6-mediated TGFb activation in radiation lung fibrosis
-
批准号:7258893
-
项目类别:
-
资助金额:$40.06万
-
财政年份:2004
-
负责人:John S Munger
-
依托单位:
avb6-mediated TGFb activation in radiation lung fibrosis
-
批准号:6813434
-
项目类别:
-
资助金额:$42.25万
-
财政年份:2004
-
负责人:John S Munger
-
依托单位:
avb6-mediated TGFb activation in radiation lung fibrosis
-
批准号:6917903
-
项目类别:
-
资助金额:$42.25万
-
财政年份:2004
-
负责人:John S Munger
-
依托单位:
ACTIVATION OF LATENT TGFB BY THE INTEGRIN ALPHA VB6
-
批准号:6499025
-
项目类别:
-
资助金额:$41.51万
-
财政年份:2000
-
负责人:John S Munger
-
依托单位:
ACTIVATION OF LATENT TGFB BY THE INTEGRIN ALPHA VB6
-
批准号:6351591
-
项目类别:
-
资助金额:$40.64万
-
财政年份:2000
-
负责人:John S Munger
-
依托单位:
Activation of latent TGF-beta by integrins
-
批准号:7116401
-
项目类别:
-
资助金额:$41.26万
-
财政年份:2000
-
负责人:John S Munger
-
依托单位:
ACTIVATION OF LATENT TGFB BY THE INTEGRIN ALPHA VB6
-
批准号:6029618
-
项目类别:
-
资助金额:$42.28万
-
财政年份:2000
-
负责人:John S Munger
-
依托单位:
ACTIVATION OF LATENT TGFB BY THE INTEGRIN ALPHA VB6
-
批准号:6629044
-
项目类别:
-
资助金额:$42.75万
-
财政年份:2000
-
负责人:John S Munger
-
依托单位:
Activation of latent TGF-beta by integrins
-
批准号:7244316
-
项目类别:
-
资助金额:$40.06万
-
财政年份:2000
-
负责人:John S Munger
-
依托单位:
Activation of latent TGF-beta by integrins
-
批准号:6826302
-
项目类别:
-
资助金额:$42.25万
-
财政年份:2000
-
负责人:John S Munger
-
依托单位:
TGF BETA ACTIVATION IN PULMONARY DISEASE
-
批准号:6305947
-
项目类别:
-
资助金额:$2.1万
-
财政年份:1999
-
负责人:John S Munger
-
依托单位:
TGF BETA ACTIVATION IN PULMONARY DISEASE
-
批准号:6115761
-
项目类别:
-
资助金额:$2.1万
-
财政年份:1998
-
负责人:John S Munger
-
依托单位:
TGF BETA ACTIVATION IN PULMONARY DISEASE
-
批准号:6276995
-
项目类别:
-
资助金额:$2.03万
-
财政年份:1997
-
负责人:John S Munger
-
依托单位:
TGF BETA ACTIVATION IN PULMONARY DISEASE
-
批准号:6246912
-
项目类别:
-
资助金额:$2.39万
-
财政年份:1997
-
负责人:John S Munger
-
依托单位: